(Q39264721)

10 September 2017

title

Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators (English)

1 reference

10 September 2017

Jiafu Wang

2

0 references

author name string

J Oliver Dolly

series ordinal

1

1 reference

10 September 2017

Tomas H Zurawski

series ordinal

3

1 reference

10 September 2017

Jianghui Meng

series ordinal

4

1 reference

10 September 2017

language of work or name

English

0 references

publication date

5 July 2011

1 reference

10 September 2017

1 reference

10 September 2017

volume

278

1 reference

10 September 2017

issue

23

1 reference

10 September 2017

page(s)

4454-4466

1 reference

Membrane fusion: grappling with SNARE and SM proteins

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Different mechanisms of inhibition of nerve terminals by botulinum and snake presynaptic neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Botulinum neurotoxin: a marvel of protein design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Crystal structure of botulinum neurotoxin type A and implications for toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Structural basis of cell surface receptor recognition by botulinum neurotoxin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Expression and Purification of the Light Chain of Botulinum Neurotoxin A: A Single Mutation Abolishes Its Cleavage of SNAP-25 and Neurotoxicity after Reconstitution with the Heavy Chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Two protein trafficking processes at motor nerve endings unveiled by botulinum neurotoxin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Plasma membrane localization signals in the light chain of botulinum neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Impaired nociception and pain sensation in mice lacking the capsaicin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

An update on the neurologic applications of botulinum toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Disease-oriented approach to botulinum toxin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Current clinical applications of botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08205.X

10.1111/J.1742-4658.2011.08205.X

21 January 2018

Identifiers

DOI

1 reference

release_loywvla7kbf2vd463djpp3glom

10 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/loywvla7kbf2vd463djpp3glom

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference